Julie H Ostrander Selected Research

Julie H Ostrander Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2008
7	Neoplasms (Cancer) 01/2021 - 12/2010
1	Lobular Carcinoma 01/2024
1	Hypoxia (Hypoxemia) 11/2018
1	Triple Negative Breast Neoplasms 11/2018
1	Carcinogenesis 01/2016
1	Residual Neoplasm 01/2010

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 01/2021 - 12/2010
3	Tamoxifen FDA LinkGeneric 01/2021 - 08/2008
3	Estrogen ReceptorsIBA 01/2018 - 01/2010
2	Glutamic Acid (Glutamate)FDA Link 01/2024 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 11/2018
2	Phenobarbital (Luminal)FDA Link 01/2021 - 11/2018
2	Steroid Receptors (Steroid Receptor)IBA 01/2020 - 11/2018
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2018 - 01/2016
2	p38 Mitogen-Activated Protein KinasesIBA 11/2018 - 09/2011
2	human PELP1 proteinIBA 01/2018 - 01/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2011 - 12/2010
1	Riluzole FDA LinkGeneric 01/2024
1	Progesterone FDA LinkGeneric 01/2020
1	LigandsIBA 01/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	GlucocorticoidsIBA 01/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Proline (L-Proline)FDA Link 01/2015
1	Leucine (L-Leucine)FDA Link 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Serum-Free Culture MediaIBA 01/2012
1	Epidermal Growth Factor (EGF)IBA 09/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2011
1	HexokinaseIBA 02/2011
1	Glucose (Dextrose)FDA LinkGeneric 02/2011
1	2- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA 02/2011
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2011
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2010
1	AcidsIBA 01/2010
1	protoporphyrin IXIBA 01/2010

Therapy/Procedure

4	Therapeutics 01/2021 - 12/2010
2	Drug Therapy (Chemotherapy) 01/2021 - 11/2018
1	Chemoprevention 01/2015